Here are what the editors at HealthDay consider to be the most important developments in Family Practice for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Long-Term Reduction in CRC Risk After Negative Colonoscopy
MONDAY, Dec. 31, 2018 (HealthDay News) — For average-risk patients, a negative colonoscopy result is associated with a long-term reduction in the risk for colorectal cancer and related deaths, according to a study published online Dec. 17 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Incidence of End-Stage Kidney Disease Up in Australia
MONDAY, Dec. 31, 2018 (HealthDay News) — For nonindigenous people with type 2 diabetes mellitus (T2DM) in Australia, the age-standardized incidence of end-stage kidney disease (ESKD) increased from 2002 to 2013, according to a study published online Dec. 19 in the American Journal of Kidney Diseases.
Abstract/Full Text (subscription or payment may be required)
Catheter Ablation Tops Drug Therapy for A-Fib in Heart Failure
MONDAY, Dec. 31, 2018 (HealthDay News) — Catheter ablation is better than drug therapy for the treatment of atrial fibrillation (AF) in patients with heart failure, according to a review published online Dec. 25 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Nurse-Led Program in Primary Care Can Up Detection of Liver Dz
MONDAY, Dec. 31, 2018 (HealthDay News) — A nurse-led primary care intervention can increase the number of new diagnoses of liver disease, according to a study published online Dec. 21 in PLOS ONE.
ACOG Updates Guidelines for Gestational HTN, Preeclampsia
FRIDAY, Dec. 28, 2018 (HealthDay News) — The American College of Obstetricians & Gynecologists (ACOG) has updated its guidance on the management of gestational hypertension and preeclampsia as well as chronic hypertension in pregnant women; the two practice bulletins were published in the January issue of Obstetrics & Gynecology.
Gestational Hypertension and Preeclampsia
Chronic Hypertension in Pregnancy
Effect Sizes Uncertain for Meds Versus Placebo in Knee OA
FRIDAY, Dec. 28, 2018 (HealthDay News) — For patients with knee osteoarthritis and at least 12 months of follow-up, there is uncertainty around estimates of effect size for the change in pain in association with medications versus placebo, according to a meta-analysis published in the Dec. 25 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Second-Line Antidiabetic Meds May Impact Cardiovascular Risk
Barriers to Pediatric Cancer Clinical Trial Participation Identified 
Female Emergency Medicine Physicians Order More Tests, Admit More Patients 
Greater Physician Knowledge Linked to Lower Use of Low-Value Services 
Irritable Patients Make Emergency Medicine Physicians More Stressed .jpg)
Warning Symptoms, Clinical History Can Predict Sudden Cardiac Arrest 
Protocol IDs Patients Who Can Be Treated While Seated in the ED 
Emergency Presentation of Cancer Common in Older Adults 
High-Dose Intravenous Vitamin C May Benefit Trauma Patients 
